Viral infection: An evolving insight into the signal transduction pathways responsible for the innate immune response

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Kotwal, Girish J ^a   Hatch, Steven ^b   Marshall, William L ^b  

^a University of Medicine and Health Sciences   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

EID: 84873834822     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/131457     Document Type: Review

References (92)

1. Janeway C. A. Jr., Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symposia on Quantitative Biology 1989 54 1 1 13 2-s2.0-0024955886 (Pubitemid 20177564)
2. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology 2004 5 7 730 737 2-s2.0-3242813113 10.1038/ni1087 (Pubitemid 39023305)
3. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K. J., Takeuchi O., Akira S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology 2005 6 10 981 988 2-s2.0-27144440523 10.1038/ni1243 (Pubitemid 41486182)
4. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y. M., Gale M., Akira S., Yonehara S., Kato A., Fujita T., Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. Journal of Immunology 2005 175 5 2851 2858 2-s2.0-23844438864 (Pubitemid 41170502)
5. Kalverda A. P., Thompson G. S., Vogel A., Schröder M., Bowie A. G., Khan A. R., Homans S. W., Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. Journal of Molecular Biology 2009 385 3 843 853 2-s2.0-58149107158 10.1016/j.jmb.2008.09. 048
6. Tanner N. K., Linder P., DExD/H box RNA helicases: from generic motors to specific dissociation functions. Molecular Cell 2001 8 2 251 262 2-s2.0-0034857262 10.1016/S1097-2765(01)00329-X (Pubitemid 32831543)
7. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B. G., Schoenemeyer A., Yamamoto M., Akira S., Fitzgerald K. A., The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. Journal of Immunology 2005 175 8 5260 5268 2-s2.0-26844503987 (Pubitemid 41456411)
8. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., Fujita T., Akira S., Takeuchi O., LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1512 1517 2-s2.0-76549109497 10.1073/pnas.0912986107
9. Seth R. B., Sun L., Ea C. K., Chen Z. J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- B and IRF3. Cell 2005 122 5 669 682 2-s2.0-24144461689 10.1016/j.cell.2005.08.012 (Pubitemid 41242633)
10. Sun Q., Sun L., Liu H. H., Chen X., Seth R. B., Forman J., Chen Z. J., The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006 24 5 633 642 2-s2.0-33646592188 10.1016/j.immuni.2006.04.004 (Pubitemid 43728147)
11. Akira S., Mammalian Toll-like receptors. Current Opinion in Immunology 2003 15 2 238 10.1016/S0952-7915(03)00005-0 (Pubitemid 36287532)
12. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S., Species-specific recognition of single-stranded RNA via Till-like receptor 7 and 8. Science 2004 303 5663 1526 1529 2-s2.0-1542317578 10.1126/science.1093620 (Pubitemid 38314424)
13. Sharma S., TenOever B. R., Grandvaux N., Zhou G. P., Lin R., Hiscott J., Triggering the interferon antiviral response through an IKK-related pathway. Science 2003 300 5622 1148 1151 2-s2.0-0038363463 10.1126/science.1081315 (Pubitemid 36583100)
14. Silverman N., Maniatis T., NF- B signaling pathways in mammalian and insect innate immunity. Genes and Development 2001 15 18 2321 2342 2-s2.0-0035883151 10.1101/gad.909001 (Pubitemid 32899738)
15. McWhirter S. M., Fitzgerald K. A., Rosains J., Rowe D. C., Golenbock D. T., Maniatis T., IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 233 238 2-s2.0-0345827590 10.1073/pnas.2237236100 (Pubitemid 38084233)
16. Doyle S. E., Vaidya S. A., O'Connell R., Dadgostar H., Dempsey P. W., Wu T. T., Rao G., Sun R., Haberland M. E., Modlin R. L., Cheng G., IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002 17 3 251 263 2-s2.0-18644376284 10.1016/S1074-7613(02)00390-4 (Pubitemid 35279547)
17. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E. E. M., Trinchieri G., Caux C., Garrone P., A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. Journal of Experimental Medicine 2005 201 9 1435 1446 2-s2.0-18644364701 10.1084/jem.20041964 (Pubitemid 40664087)
18. Whitmore M. M., DeVeer M. J., Edling A., Oates R. K., Simons B., Lindner D., Williams B. R. G., Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes eahanced antitumor activity. Cancer Research 2004 64 16 5850 5860 2-s2.0-4143131229 10.1158/0008-5472.CAN-04-0063 (Pubitemid 39095586)
19. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S. O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., Beutler B., Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003 424 6950 743 748 2-s2.0-0042679529 10.1038/nature01889 (Pubitemid 37021696)
20. Franchi L., Eigenbrod T., Muñoz-Planillo R., Nuñez G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature Immunology 2009 10 3 241 247 2-s2.0-60749104683 10.1038/ni.1703
21. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D. R., Latz E., Fitzgerald K. A., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009 458 7237 514 518 2-s2.0-63649133278 10.1038/nature07725
22. Lamkanfi M., Dixit V. M., Inflammasomes: guardians of cytosolic sanctity. Immunological Reviews 2009 227 1 95 105 2-s2.0-58049202273 10.1111/j.1600-065X. 2008.00730.x
23. Ishii K. J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., Akira S., A toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nature Immunology 2006 7 1 40 48 2-s2.0-29244471275 10.1038/ni1282 (Pubitemid 41823867)
24. Stetson D. B., Medzhitov R., Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006 24 1 93 103 2-s2.0-30444450839 10.1016/j.immuni.2005.12.003 (Pubitemid 43077203)
25. Wang Z., Choi M. K., Ban T., Yanai H., Negishi H., Lu Y., Tamura T., Takaoka A., Nishikura K., Taniguchi T., Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proceedings of the National Academy of Sciences of the United States of America 2008 105 14 5477 5482 2-s2.0-44449157593 10.1073/pnas.0801295105 (Pubitemid 351753888)
26. Bikard D., Marraffini L. A., Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. Current Opinion in Immunology 2012 24 1 15 20 2-s2.0-84857041376 10.1016/j.coi.2011.10. 005
27. Cheng W. C., Hardwick J. M., A quorum on bacterial programmed cell death. Molecular Cell 2007 28 4 515 517 2-s2.0-36248943145 10.1016/j.molcel.2007.11. 008 (Pubitemid 350137802)
28. Han Y.-H., Luo Y.-J., Wu Q., Jovel J., Wang X.-H., Aliyari R., Han C., Li W.-X., Ding S.-W., RNA-based immunity terminates viral infection in adult Drosophila in the absence of viral suppression of RNA interference: characterization of viral small interfering RNA populations in wild-type and mutant flies. Journal of Virology 2011 85 24 13153 13163 2-s2.0-82955225747 10.1128/JVI.05518-11
29. Wang J. H., Valanne S., Ramet M., Drosophila as a model for antiviral immunity. World Journal of Biological Chemistry 2010 1 5 151 159
30. Galiana-Arnoux D., Dostert C., Schneemann A., Hoffmann J. A., Imler J. L., Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila. Nature Immunology 2006 7 6 590 597 2-s2.0-33744494279 10.1038/ni1335 (Pubitemid 43797340)
31. Crook N. E., Clem R. J., Miller L. K., An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. Journal of Virology 1993 67 4 2168 2174 2-s2.0-0027537461 (Pubitemid 23088392)
32. Hay B. A., Wolff T., Rubin G. M., Expression of baculovirus P35 prevents cell death in Drosophila. Development 1994 120 8 2121 2129 2-s2.0-0028141705 (Pubitemid 24232280)
33. Kuo R. L., Zhao C., Malur M., Krug R. M., Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon- β transcription. Virology 2010 408 2 146 158 2-s2.0-78149413053 10.1016/j.virol.2010.09.012
34. Langland J. O., Jacobs B. L., The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 2002 299 1 133 141 2-s2.0-0036037388 10.1006/viro.2002.1479 (Pubitemid 35007518)
35. DiPerna G., Stack J., Bowie A. G., Boyd A., Kotwal G., Zhang Z., Arvikar S., Latz E., Fitzgerald K. A., Marshall W. L., Poxvirus protein N1L targets the I- B kinase complex, inhibits signaling to NF- B by the tumor necrosis factor superfamily of receptors, and inhibits NF- B and IRF3 signaling by toll-like receptors. The Journal of Biological Chemistry 2004 279 35 36570 36578 2-s2.0-4344600796 10.1074/jbc.M400567200 (Pubitemid 39129000)
36. Bowie A., Kiss-Toth E., Symons J. A., Smith G. L., Dower S. K., O'Neill L. A. J., A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proceedings of the National Academy of Sciences of the United States of America 2000 97 18 10162 10167 2-s2.0-0034730146
37. Gonzlez J. M., Esteban M., A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virology Journal 2010 7, article 59 2-s2.0-77949443152 10.1186/1743-422X-7-59
38. Johnson C. L., Owen D. M., Gale M. Jr., Functional and therapeutic analysis of hepatitis C virus NS3 · 4A protease control of antiviral immune defense. The Journal of Biological Chemistry 2007 282 14 10792 10803 2-s2.0-34249845169 10.1074/jbc.M610361200 (Pubitemid 47093463)
39. Hosui A., Ohkawa K., Ishida H., Sato A., Nakanishi F., Ueda K., Takehara T., Kasahara A., Sasaki Y., Hori M., Hayashi N., Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon- γ stimuli. The Journal of Biological Chemistry 2003 278 31 28562 28571 2-s2.0-0042208069 10.1074/jbc.M210485200 (Pubitemid 36935761)
40. Gale M. J. Jr., Korth M. J., Katze M. G., Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clinical and Diagnostic Virology 1998 10 2-3 157 162 2-s2.0-0344765507 10.1016/S0928-0197(98)00034-8 (Pubitemid 28399034)
41. Moss B., Knipe D. M., Howley P. M., Poxviridae: the viruses and their replication. Fields Virology 2001 2 Philadelphia, Pa, USA Lippincott, Williams & Wilkins 2849 2883
42. Li K., Foy E., Ferreon J. C., Nakamura M., Ferreon A. C. M., Ikeda M., Ray S. C., Gale M., Lemon S. M., Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2992 2997 2-s2.0-14544280209 10.1073/pnas.0408824102 (Pubitemid 40299904)
43. Parisien J. P., Bamming D., Komuro A., Ramachandran A., Rodriguez J. J., Barber G., Wojahn R. D., Horvath C. M., A shared interface mediates Paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. Journal of Virology 2009 83 14 7252 7260 2-s2.0-67650439286 10.1128/JVI.00153-09
44. Gregory S. M., Davis B. K., West J. A., Taxman D. J., Matsuzawa S. I., Reed J. C., Ting J. P. Y., Damania B., Discovery of a viral NLR homolog that inhibits the inflammasome. Science 2011 331 6015 330 334 2-s2.0-78751680633 10.1126/science.1199478
45. Rahman M. M., McFadden G., Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple toll-like receptors, which independently activate the inflammasome and NF- B innate response pathways. Journal of Virology 2011 85 23 12505 12517 2-s2.0-81255123292 10.1128/JVI.00410-11
46. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J. L., Schröter M., Scaffidi C., Krammer P. H., Peter M. E., Tschopp J., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997 386 6624 517 521 2-s2.0-0030970013 10.1038/386517a0 (Pubitemid 27164081)
47. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A., Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proceedings of the National Academy of Sciences of the United States of America 1993 90 18 8479 8483 2-s2.0-0027260656 (Pubitemid 23277692)
48. Marshall W. L., Yim C., Gustafson E., Graf T., Sage D. R., Hanify K., Williams L., Fingeroth J., Finberg R. W., Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. Journal of Virology 1999 73 6 5181 5185 2-s2.0-0033057256 (Pubitemid 29246784)
49. Sarid R., Sato T., Bohenzky R. A., Russo J. J., Chang Y., Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nature Medicine 1997 3 3 293 298 2-s2.0-0031054439 10.1038/nm0397-293 (Pubitemid 27112926)
50. Sedlak T. W., Oltvai Z. N., Yang E., Wang K., Boise L. H., Thompson C. B., Korsmeyer S. J., Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of the National Academy of Sciences of the United States of America 1995 92 17 7834 7838 2-s2.0-0029097470 10.1073/pnas.92.17.7834
51. Huang D. C. S., Adams J. M., Cory S., The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO Journal 1998 17 4 1029 1039 2-s2.0-0032481346 10.1093/emboj/17.4.1029 (Pubitemid 28077657)
52. Gross A., McDonnell J. M., Korsmeyer S. J., BCL-2 family members and the mitochondria in apoptosis. Genes and Development 1999 13 15 1899 1911 2-s2.0-0033179760 (Pubitemid 29407357)
53. Mandal M., Maggirwar S. B., Sharma N., Kaufmann S. H., Sun S. C., Kumar R., Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF- B signaling pathway. The Journal of Biological Chemistry 1996 271 48 30354 30359 2-s2.0-0029849215 10.1074/jbc.271.48.30354 (Pubitemid 26404036)
54. Kirshenbaum L. A., Bcl-2 intersects the NF B signalling pathway and suppresses apoptosis in ventricular myocytes. Clinical and Investigative Medicine 2000 23 5 322 330 2-s2.0-0033748413
55. Regula K. M., Ens K., Kirshenbaum L. A., IKK β is required for Bcl-2-mediated NF- B activation in ventricular myocytes. The Journal of Biological Chemistry 2002 277 41 38676 38682 2-s2.0-0037064129 10.1074/jbc.M206175200 (Pubitemid 35154728)
56. Li Q., Estepa G., Memet S., Israel A., Verma I. M., Complete lack of NF- B activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes and Development 2000 14 14 1729 1733 2-s2.0-0034661272 (Pubitemid 30602991)
57. Karin M., Ben-Neriah Y., Phosphorylation meets ubiquitination: the control of NF- B activity. Annual Review of Immunology 2000 18 621 663 2-s2.0-0034084163 10.1146/annurev.immunol.18.1.621 (Pubitemid 30365393)
58. Hartig J. V., Förstemann K., Loqs-PD and R2D2 define independent pathways for RISC generation in Drosophila. Nucleic Acids Research 2011 39 9 3836 3851 2-s2.0-79954630204 10.1093/nar/gkq1324
59. Hussain M., Taft R. J., Asgari S., An insect virus-encoded microrna regulates viral replication. Journal of Virology 2008 82 18 9164 9170 2-s2.0-50949097481 10.1128/JVI.01109-08
60. Jovanovic G., Engl C., Buck M., Physical, functional and conditional interactions between ArcAB and phage shock proteins upon secretin-induced stress in Escherichia coli. Molecular Microbiology 2009 74 1 16 28 2-s2.0-70350180756 10.1111/j.1365-2958.2009.06809.x
61. Zambon R. A., Nandakumar M., Vakharia V. W., Wu L. P., The Toll pathway is important for an antiviral response in Drosophila. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7257 7262 2-s2.0-18844411853 10.1073/pnas.0409181102 (Pubitemid 40696366)
62. Deddouche S., Matt N., Budd A., Mueller S., Kemp C., Galiana-Arnoux D., Dostert C., Antoniewski C., Hoffmann J. A., Imler J. L., The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in drosophila. Nature Immunology 2008 9 12 1425 1432 2-s2.0-56349115840 10.1038/ni.1664
63. Grether M. E., Abrams J. M., Agapite J., White K., Steller H., The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Genes and Development 1995 9 14 1694 1708 2-s2.0-0029161958
64. LaCasse E. C., Baird S., Korneluk R. G., MacKenzie A. E., The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998 17 25 3247 3259 2-s2.0-0032410818 (Pubitemid 29043977)
65. Alcamí A., Symons J. A., Smith G. L., The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. Journal of Virology 2000 74 23 11230 11239 2-s2.0-0034467234 10.1128/JVI.74.23.11230-11239.2000 (Pubitemid 32223991)
66. Billings B., Smith S. A., Zhang Z., Lahiri D. K., Kotwal G. J., Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain. Annals of the New York Academy of Sciences 2004 1030 297 302 2-s2.0-15044342029 10.1196/annals.1329.037 (Pubitemid 40378926)
67. Zhang Z., Abrahams M. R., Hunt L. A., Suttles J., Marshall W., Lahiri D. K., Kotwal G. J., The vaccinia virus N1L protein influences cytokine secretion in vitro after infection. Annals of the New York Academy of Sciences 2005 1056 69 86 2-s2.0-29744465281 10.1196/annals.1352.005 (Pubitemid 43030968)
68. Harte M. T., Haga I. R., Maloney G., Gray P., Reading P. C., Bartlett N. W., Smith G. L., Bowie A., O'Neill L. A. J., The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. Journal of Experimental Medicine 2003 197 3 343 351 2-s2.0-0037415598 10.1084/jem.20021652 (Pubitemid 36184241)
69. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D. J., Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme. Cell 1992 69 4 597 604 2-s2.0-0026728952 10.1016/0092-8674(92)90223-Y
70. Mills R., Rozanov M., Lomsadze A., Tatusova T., Borodovsky M., Improving gene annotation of complete viral genomes. Nucleic Acids Research 2003 31 23 7041 7055 2-s2.0-0345099561 10.1093/nar/gkg878 (Pubitemid 37508811)
71. Huang Q., Petros A. M., Virgin H. W., Fesik S. W., Olejniczak E. T., Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. Journal of Molecular Biology 2003 332 5 1123 1130 2-s2.0-0041885229 10.1016/j.jmb.2003.08.007 (Pubitemid 37108804)
72. Altmann M., Hammerschmidt W., Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biology 2005 3 12, article e404 2-s2.0-34548106895
73. Bump N. J., Hackett M., Hugunin M., Seshagiri S., Brady K., Chen P., Ferenz C., Franklin S., Ghayur T., Li P., Licari P., Mankovich J., Shi L., Greenberg A. H., Miller L. K., Wong W. W., Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995 269 5232 1885 1888 2-s2.0-0028817947
74. Meinl E., Fickenscher H., Thome M., Tschopp J., Fleckenstein B., Anti-apoptotic strategies of lymphotropic viruses. Immunology Today 1998 19 10 474 479 2-s2.0-0032189764 10.1016/S0167-5699(98)01309-7 (Pubitemid 28451890)
75. Kondo T., Yokokura T., Nagata S., Activation of distinct caspase-like proteases by Fas and reaper in Drosophila cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 22 11951 11956 2-s2.0-0030700489 10.1073/pnas.94.22.11951 (Pubitemid 27467823)
76. Field N., Low W., Daniels M., Howell S., Daviet L., Boshoff C., Collins M., KSHV vFLIP binds to IKK- γ to activate IKK. Journal of Cell Science 2003 116 18 3721 3728 2-s2.0-0141502126 10.1242/jcs.00691 (Pubitemid 37185301)
77. Diaz-Guerra M., Kahn J. S., Esteban M., A mutation of the nucleoside triphosphate phosphohydrolase I (NPH-I) gene confers sensitivity of vaccinia virus to interferon. Virology 1993 197 1 485 491 2-s2.0-0027448566 10.1006/viro.1993.1618
78. Thompson A. J. V., McHutchison J. G., Antiviral resistance and specifically targeted therapy for HCV (STAT-C). Journal of Viral Hepatitis 2009 16 6 377 387 2-s2.0-65549160381 10.1111/j.1365-2893.2009.01124.x
79. Chung H., Watanabe T., Kudo M., Chiba T., Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2. Journal of Infectious Diseases 2010 202 6 853 861 2-s2.0-77955935168 10.1086/655812
80. Lin W., Choe W. H., Hiasa Y., Kamegaya Y., Blackard J. T., Schmidt E. V., Chung R. T., Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 2005 128 4 1034 1041 2-s2.0-17144382003 10.1053/j.gastro.2005.02.006 (Pubitemid 40523553)
81. Hartman A. L., Towner J. S., Nichol S. T., A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza a virus. Virology 2004 328 2 177 184 2-s2.0-5344258197 10.1016/j.virol.2004.07.006 (Pubitemid 39349467)
82. Pichlmair A., Schulz O., Tan C. P., Näslund T. I., Liljeström P., Weber F., Reis E Sousa C., RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006 314 5801 997 1001 2-s2.0-33750984771 10.1126/science.1132998 (Pubitemid 44749946)
83. Watanabe Y., Ohtaki N., Hayashi Y., Ikuta K., Tomonaga K., Autogenous translational regulation of the borna disease virus negative control factor X from polycistronic mRNA using host RNA helicases. PLoS Pathogens 2009 5 11 2-s2.0-73549124826 10.1371/journal.ppat.1000654 e1000654
84. Strack P. R., Frey M. W., Rizzo C. J., Cordova B., George H. J., Meade R., Ho S. P., Corman J., Tritch R., Korant B. D., Apoptosis mediated by HIV protease is preceded by cleavage of bcl-2. Proceedings of the National Academy of Sciences of the United States of America 1996 93 18 9571 9576 2-s2.0-9544225179 10.1073/pnas.93.18.9571 (Pubitemid 26296649)
85. Rasola A., Gramaglia D., Boccaccio C., Comoglio P. M., Apoptosis enhancement by the HIV-1 Nef protein. Journal of Immunology 2001 166 1 81 88 2-s2.0-0035163622 (Pubitemid 32038419)
86. Tuosto L., Marinari B., Andreotti M., Federico M., Piccolella E., Vav exchange factor counteracts the HIV-1 Nef-mediated decrease of plasma membrane GM1 and NF-AT activity in T cells. European Journal of Immunology 2003 33 8 2186 2196 2-s2.0-0042977420 10.1002/eji.200323682 (Pubitemid 37010036)
87. Varin A., Manna S. K., Quivy V., Decrion A. Z., Van Lint C., Herbein G., Aggarwal B. B., Exogenous Nef protein activates NF- B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells: role in AIDS pathogenesis. The Journal of Biological Chemistry 2003 278 4 2219 2227 2-s2.0-0037462825 10.1074/jbc.M209622200 (Pubitemid 36801289)
88. Okumura A., Alce T., Lubyova B., Ezelle H., Strebel K., Pitha P. M., HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008 373 1 85 97 2-s2.0-40649114040 10.1016/j.virol.2007.10.042
89. Thomson J. A., Perni R. B., Hepatitis C virus NS3 · 4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic. Current Opinion in Drug Discovery and Development 2006 9 5 606 617 2-s2.0-33748603755 (Pubitemid 44378829)
90. Bartlett N., Symons J. A., Tscharke D. C., Smith G. L., The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. Journal of General Virology 2002 83 8 1965 1976 2-s2.0-0036328156 (Pubitemid 34851238)
91. Kotwal G. J., Hugin A. W., Moss B., Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 1989 171 2 579 587 2-s2.0-0024345810 (Pubitemid 19210402)
92. Cheltsov A. V., Aoyagi M., Aleshin A., Yu E. C. W., Gilliland T., Zhai D., Bobkov A. A., Reed J. C., Liddington R. C., Abagyan R., Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. Journal of Medicinal Chemistry 2010 53 10 3899 3906 2-s2.0-77952679795 10.1021/jm901446n